The role of oligodendrocytes in the molecular pathobiology and potential molecular treatment of cervical spondylotic myelopathy

Current Medicinal Chemistry

Volumn 17, Issue 11, 2010, Pages 1048-1058

  Karadimas, S K ^a   Gialeli, Ch ^b   Klironomos, G ^a   Tzanakakis, G N ^c   Panagiotopoulos, E ^a   Karamanos, N K ^b   Gatzounis, G ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

Antiapoptotic therapy; Cervical spondylotic myelopathy; Demyelination; Oligodendrocyte apoptosis; Oligodendrocyte progenitor cells; Remyelination

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACTIVIN A; ADENOVIRUS VECTOR; APOPTOSIS SIGNAL REGULATING KINASE 1; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXAMETHASONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ETANERCEPT; FAS ANTIGEN; GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; METHYLPREDNISOLONE; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELIN; NEURONAL NITRIC OXIDE SYNTHASE; NEUROTROPHIN 3; PREGABALIN; PROTEIN BCL XL; STAT5 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TAMOXIFEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; UNINDEXED DRUG;

APOPTOSIS; CELL MATURATION; CERVICAL SPONDYLOSIS; DECOMPRESSION SURGERY; DEMYELINATION; DRUG MECHANISM; HUMAN; MYELINATION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; REMYELINIZATION; REVIEW; SPINAL CORD INJURY; SPONDYLOSIS;

ANIMALS; APOPTOSIS; CERVICAL VERTEBRAE; DOGS; MYELIN SHEATH; OLIGODENDROGLIA; SPINAL CORD DISEASES; SPINAL OSTEOPHYTOSIS;

EID: 77950671897     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790820598     Document Type: Review

References (145)

1. Fehlings, M.G.; Skaf, G. A review of the pathophysiology of cervical spondylotic myelopathy with insights for potential novel mechanisms drawn from traumatic spinal cord injury. Spine, 1998, 23, 2730-2737 (Pubitemid 29013985)
2. Baptiste, D.C.; Fehlings, M.G. Pathophysiology of cervical myelopathy. Spine J., 2006, 6, 190S-197S.
3. Bohlman, H.H.; Emery, S.E. The pathophysiology of cervical spondylosis and myelopathy. Spine, 1998, 13, 843-846.
4. Swagerty, D.L. Jr. Cervical spondylotic myelopathy: a cause of gait disturbance and falls in the elderly. Kans. Med., 1994, 95, 226-227, 229.
5. McCormack, B.M.; Weinstein, P.R. Cervical spondylosis. An update. West. J. Med., 1996, 165, 43-51.
6. Rao, R. Neck pain, cervical radiculopathy, and cervical myelopathy: pathophysiology, natural history. Clinical evaluation. J. Bone Joint Surg. Am., 2002, 84-A, 1872-1881
7. Nakamura, I.; Ikegawa, S.; Okawa, A.; Okuda, S.; Koshizuka, Y.; Kawaguchi, H.; Nakamura, K.; Koyama, T.; Goto, S.; Toguchida, J.; Matsushita, M.; Ochi, T.; Takaoka, K.; Nakamura, Y. Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Hum. Genet., 1999, 104(6), 492-497 (Pubitemid 29370925)
8. Tarlov, L.M.; Klinger, H.; Vitale, S. Spinal cord compression studies. I. Experimental techniques to produce acute and gradual compression. Arch. Neurol. Psychiat., 1953, 70, 813-819
9. Hukuda, S.; Wilson, C.B. Experimental cervical myelopathy: effects of compression and ischemia on the canine cervical cord. J. Neurosurg., 1972, 37, 631-652.
10. Gooding, M.R.; Wilson, C.B.; Hoff, J.T. Experimental cervical myelopathy: effects of ischemia and compression of the canine cervical spinal cord. J. Neurosurg., 1975, 43, 9-17.
11. Ushio, Y.; Posner, R.; Posner, J.B.; Shapiro, W.R. Experimental cord compression by epidural neoplasms. Neurology, 1977, 27, 422-429.
12. Ikeda, H.; Ushio, Y.; Hayakawa, T.; Mogami, H. Edema and circulatory disturbance in the spinal cord compressed by epidural neoplasms in rabbits. J. Neurosurg., 1980, 52, 203-209.
13. Manabe, S.; Tanaka, H.; Higo, Y.; Park, P.; Ohno, T.; Tateishi, A. Experimental analysis of spinal cord compressed by spinal metastasis. Spine, 1989, 14, 1308-1315. (Pubitemid 20036762)
14. Delattre, J.Y.; Arbit, E.; Thaler, H.T.; Rosenblum, M.K.; Posner, J.B. A dose-response study of dexamethasone in a model of spinal cord compression caused by epidural tumor. J. Neurosurg., 1989, 70, 920-925.
15. Delattre, J.Y.; Arbit, E.; Rosenblum, M.K.; Thaler, H.T.; Lau, N.; Galicich, J.H.; Posner, J.B. High dose versus low dose dexamethasone in experimental epidural spinal cord compression. Neurosurgery, 1988, 22, 1005-1007.
16. Izumida, M. A chronic spinal cord compression model in a rat with a 354A tumor. Nippon Seikeigeka Gakkai Zasshi, 1995, 69, 977-991.
17. Schramm, J.; Hashizume, K.; Fukushima, T.; Takahashi, H. Experimental spinal cord injury produced by slow, graded compression. Alterations of cortical and spinal evoked potentials. J. Neurosurg., 1979, 50(1), 48-57. (Pubitemid 9077559)
18. Tanaka, H. Experimental study of cervical spondylotic myelopathy - cervical canal stenosis [Japanese]. Nippon Seikeigeka Gakkai Zasshi, 1980, 54, 161-176. (Pubitemid 10083675)
19. Shinomiya, K.; Mutoh, N.; Furuya, K. Study of experimental cervical spondylotic myelopathy. Spine, 1992, 17(suppl 10), S383-S387.
20. al-Mefty, O.; Harkey, H.L.; Marawi, I.; Haines, D.E.; Peeler, D.F.; Wilner, H.I.; Smith, R.R.; Holaday, H.R.; Haining, J.L.; Russell, W.F.; Harrison, B.; Middleton, T.H. Experimental chronic compressive cervical myelopathy. J. Neurosurg., 1993, 79, 550-561.
21. Kanchiku, T.; Taguchi, T.; Kaneko, K.; Yonemura, H.; Kawai, S.; Gondo, T. A new rabbit model for the study on cervical compressive myelopathy. J. Orthop. Res., 2001, 19(4), 605-613 (Pubitemid 32700975)
22. Baba, H.; Maezawa, Y.; Imura, S.; Kawahara, N.; Nakahashi, K.; Tomita, K. Quantitative analysis of the spinal cord motoneuron under chronic compression: an experimental observation in the mouse. J. Neurol., 1996, 243, 109-116. (Pubitemid 26026644)
23. Okawa, A.; Ikegawa, S.; Nakamura, I.; Goto, S.; Moriya, H.; Nakamura, Y. Mapping of a gene responsible for twy (tip-toe walking Yoshimura), a mouse model of ossification of the posterior longitudinal ligament of the spine (OPLL). Mamm. Genome, 1998, 9(2), 155-156 (Pubitemid 28165384)
24. Okawa, A.; Nakamura, I.; Goto, S.; Moriya, H.; Nakamura, Y.; Ikegawa, S. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat. Genet., 1998, 19(3), 271-273 (Pubitemid 28309341)
25. Uchida, K.; Baba, H.; Maezawa, Y.; Furukawa, S.; Furusawa, N.; Imura, S. Histological investigation of spinal cord lesions in the spinal hyperostotic mouse (twy/twy):morphological changes in anterior horn cells and immunoreactivity to neurotrophic factors. J. Neurol., 1998, 245, 781-793. (Pubitemid 28505273)
26. Yamaura, I.; Yone, K.; Nakahara, S.; Nagamine, T.; Baba, H.; Uchida, K.; Komiya, S. Mechanism of destructive pathologic changes in the spinal cord under chronic mechanical compression. Spine, 2002, 27, 21-26 (Pubitemid 34219521)
27. Marquardt, G.; Setzer, M.; Theisen, A.; Dettmann, E.; Seifert, V. A novel dynamic model for experimental spinal cord compression. J. Neurosurg. Spine, 2005, 2(4), 466-471
28. Kim, P.; Haisa, T.; Kawamoto, T.; Kirino, T.; Wakai, S. Delayed myelopathy induced by chronic compression in the rat spinal cord. Ann. Neurol., 2004, 55(4), 503-511 (Pubitemid 38391967)
29. Fehlings MG, Yu WR, Shannon P, Sekhon LHS: Molecular mechanisms of cell death in human cervical spondylotic myelopathy: evidence for apoptosis, death receptor expression and Caspase 3 activation. Proceeds of the 28th Annual Meeting of the Cervical Spine Research Society, 2000.
30. Smith, K.J.; Kapoor, R.; Felts P.A. Demyelination: the role of oxygen and nitrogen species. Brain Path., 1999, 9, 69-92. (Pubitemid 29056521)
31. Gelman, B.B. Iron in CNS disease. J. Neuropath. Exp. Neurol., 1995, 54, 477-486
32. Connor, J.R.; Menzies, S.L. Relationship of iron to oligodendrocytes and myelination. Glia, 1996, 17, 83-93.
33. Thorbune, S.K.; Juurlink, B.H.K. Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J. Neurochem., 1996, 67, 1014-1022
34. 2-induced oligodendrocyte cell death: A role of glutathione, mitogen activated protein kinases and caspase 3. J. Neurochem., 2004, 90, 392-404.
35. Juurlink, B.H.; Thorbune, S.K.; Hertz, L. Peroxide-scavenging deficit underlines oligodendrocyte susceptibility to oxidative stress. Glia, 1998, 22, 371-378. (Pubitemid 28129714)
36. Halliwell, B. Reactive oxygen species and the central nervous system. J. Neurochem., 1992, 59, 1609-1623
37. Richter-Landsberg, C.; Vollgraf, U. Mode of cell injury and death after hydrogen peroxide exposure in cultured oligodendroglia cells. Exp. Cell Res. 1998, 244(1), 218-229 (Pubitemid 28480869)
38. Vollgraf, U.; Wegner, M.; Richter-Landsberg, C. Activation of AP-1 and NF-kB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J. Neurochem., 1999, 73(6), 2501-2509
39. D'Souza, S.; Alinauskas, K.; McCrea, E.; Goodyear, C.; Antel, J.P. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci., 1995, 15, 7293-7300.
40. Sipe, K.J.; Srisawasdi, D.; Dantzer, R.; Kelley, K.W.; Weyhenmeyer, J.A. An endogenous 55kDa TNF receptor mediates cell death in a neural cell line. Mol. Brain Res., 1996, 38, 222-232.
41. Akassoglou, K.; Bauer, J.; Kassiotis, G.; Pasparakis, M.; Lassman, H.; Kollias, G.; Probert, L. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signalling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Path., 1998, 153, 801-813. (Pubitemid 28419033)
42. Lee, Y.B.; Yune, T.Y.; Baik, S.Y.; Shin, Y.H.; Du, S.; Rhim, H.; Lee, E.B.; Kim, Y.C.; Shin, M.L.; Markelonis, G.; Oh T.H. Role of tumor necrosis factor-a in neuronal and glial apoptosis after spinal cord injury. Exp. Neurol., 2000, 166, 190-195.
43. Kim, G.M.; Xu, J.; Xu, J.; Song, S.K.; Yan, P.; Ku, G.; Xu, X.M.; Hsu, C.Y. Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J. Neurosci., 2001, 21, 6617-6625.
44. Yune, T.Y.; Chang, M.J.; Kim, S.J.; Lee, Y.B.; Shin, S.W.; Rhim, H.; Kim, Y.C.; Shin, M.L.; Oh, Y.J.; Han, C.T.; Markelonis, G.J.; Oh, T.H. Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats. J. Neurotrauma, 2003, 20(2):207-219 (Pubitemid 36292829)
45. Ellis, R.E.; Yuan, J.; Horvitz, H.R. Mechanisms and functions of cell death. Ann. Rev. Cell Biol. 1991, 7, 663-698
46. Park, E.; Velumian, A.A.; Fehlings, M.G. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J. Neurotrauma, 2004, 21(6), 754-774
47. McDonald, J.W.; Althomsons, S.P.; Hyrc, K.L.; Choi, D.W.; Goldberg, M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 1998, 4, 291-297 (Pubitemid 28144086)
48. + exchanger. J. Neurosc. 1996, 16(2), 545-552.
49. Alberdi, E.; Sanchez-Gomez, M.V.; Torre, I.; Domercq, M.; Perez-Samartin, A.; Perez-Cerda, F.; Matute, C. Activation of kainate receptors sensitizes oligodendrocytes to complement attack. J. Neurosc. 2006, 26, 3220-3228.
50. Matute, C. Interaction between glutamate signalling and immune attack in damaging oligodendrocytes. Neuron. Glia Biol. 2007, 3(4), 281-285 (Pubitemid 351944151)
51. Sharma, K.; Wang, R.X.; Zhang, L.Y.; Yin, D.L.; Luo, X.Y.; Solomon, J.C.; Jiang, R.F.; Markos, K.; Davidson, W.; Scott, D.W.; Shi, Y.F. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol. Ther. 2000, 88(3), 333-347
52. Salvesen, G.S.; Dixit, V.M. Caspase activation: the induced-proximity model. Proc. Natl. Acad. Sci. USA, 1999, 96, 10964-10967.
53. Stennicke, H.R.; Jurgensmeier, J.M.; Shin, H.; Deveraux, Q.; Wolf, B.B.; Yang, X.; Zhou, Q.; Ellerby, H.M.; Ellerby, L.M.; Bredesen, D.; Green, D.R.; Reed, J.C.; Froelich, C.J.; Salvesen, G.S. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem., 1998, 273, 27084-32709
54. Esposti, M.D. The roles of Bid. Apoptosis, 2002, 7(5), 433-440
55. Yu, W.R.; Baptiste, D.C.; Liu, T.; Odrobina, E.; Stanisz, G.J.; Fehlings, M.G. Molecular mechanisms of spinal cord dysfunction and cell death in the spinal hyperostotic mouse: implications for the pathophysiology of human cervical spondylotic myelopathy. Neurobiol. Dis., 2009, 33(2), 149-163
56. Buntinx, M.; Vanderlocht, J.; Hellings, N.; Vandenabeele, F.; Lambrichts, I.; Raus, J.; Ameloot, M.; Stinissen, P.; Steels, P. Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury:morphology and oligodendrocyte-specific gene expression. J. Neurocytol., 2003, 32, 25-38. (Pubitemid 37518586)
57. Li, W.; Maeda, Y.; Ming, X.; Cook, S.; Chapin, J.; Husar, W.; Dowling, P. Apoptotic death following Fas activation in human oligodendrocyte hybrid cultures. J. Neurosc. Res., 2002, 69, 189-196. (Pubitemid 34734149)
58. Mclaurin, J.; Trudel, G.C.; Shaw, I.T.; Antel, J.P.; Cashman, N.R. A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J. Neurobiol., 1995, 26, 283-293.
59. Austin, J.W.; Fehlings, M.G. Molecular mechanisms of Fas-mediated cell death in oligodendrocytes. J. Neurotrauma, 2008, 25(5), 411-426 (Pubitemid 351685488)
60. Yoshino, O.; Matsuno, H.; Nakamura, H.; Yudoh, K.; Abe, Y.; Sawai, T.; Uzuki, M.; Yonehara S.; Kimura, T. The role of Fas-mediated apoptosis after traumatic spinal cord injury. Spine, 2004, 29(13), 1394-1404 (Pubitemid 38879042)
61. Casha, S.; Yu, W.R.; Fehlings, M.G. FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp. Neurol., 2005, 196(2), 390-400.
62. Demjen, D.; Klussmann, S.; Kleber, S.; Zuliani, C.; Stieltjes, B.; Metzger, C.; Hirt, U.A.; Walczak, H.; Falk, W.; Essig, M.; Edler, L.; Krammer, P.H.; Martin-Villalba, A. Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat. Med., 2004, 10(4), 389-395 (Pubitemid 38508517)
63. Yu, W.R.; Liu, T.; Fehlings, T.K.; Fehlings, M.G. Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury. Eur. J. Neurosc., 2009, 29(1), 114-131
64. Kim, D.H.; Vaccaro, A.R.; Henderson, F.C.; Benzel, E.C. Molecular biology of cervical myelopathy and spinal cord injury: role of oligodendrocyte apoptosis. Spine J., 2003, 3(6), 510-519
65. Smith, K.J.; Lassmann, H. The role of nitric oxide in multiple sclerosis. Lancet Neurol., 2002, 1, 232-241. (Pubitemid 37159185)
66. Liñares, D.; Taconis, M.; Maña, P.; Correcha, M.; Fordham, S.; Staykova, M; Willenborg, D.O. Neuronal nitric oxide synthase plays a key role in CNS demyelination. J. Neurosc., 2006, 26(49), 12672-12681 (Pubitemid 44904562)
67. Simmons, M.L.; Murphy, S. Induction of nitric oxide synthase in glial cells. J. Neurochem,. 1992, 59(3), 897-905.
68. Hewett, S.J.; Corbett, J.A.; McDaniel, M.L.; Choi, D.W. Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett., 1993, 164(1-2), 229-232
69. Merrill, J.E.; Murphy, S.P.; Mitrovic, B.; Mackenzie-Graham, A.; Dopp, J.C.; Ding, M.; Griscavage, J.; Ignarro, L.J.; Lowenstein, C.J. Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes. J. Neurosci. Res., 1997, 48(4), 372-384 (Pubitemid 27232711)
70. Arnett, H.A.; Hellendall, R.P.; Matsushima, G.K.; Suzuki, K.; Laubach, V.E.; Sherman P.; Ting, J.P. The protective role of nitric oxide in a neurotoxicant induced demyelinating model. J. Immunol., 2002, 168, 427-433 (Pubitemid 34014145)
71. Schulz, R.; Vogel, T.; Dressel, R.; Krieglstein, K. TGF-beta super-family members, ActivinA and TGF-beta1, induce apoptosis in oligodendrocytes by different pathways. Cell Tissue Res., 2008, 334(3), 327-338
72. Chen, L.; Willis, S.N.; Wei, A.; Smith, B.J.; Fletcher, J.I.; Hinds, M.G.; Colman, P.M.; Day, C.L.; Adams, J.M.; Huang, D.C.S. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allow complementary apoptotic function. Mol. Cell, 2005, 17, 393-403.
73. Kuwana, T.; Bouchier-Hayes, L.; Chipuk, J.E.; Bonzon, C.; Sullivan, B.A.; Green, D.R.; Newmeyer, D.D. BH3 domains of BH3-onlyproteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol. Cell, 2005, 17, 525-535.
74. Nakano, K.; Vousden, K.H. Puma, a novel proapoptotic gene, is induced by p53. Mol. Cell, 2001, 7, 683-694.
75. Takenouchi, T.; Setoguchi, T.; Yone, K.; Komiya, S. Expression of apoptosis signal-regulating kinase 1 in mouse spinal cord under chronic mechanical compression: possible involvement of the stress-activated mitogen-activated protein kinase pathways in spinal cord cell apoptosis. Spine, 2008, 33(18), 1943-1950
76. Nishitoh, H.; Saitoh, M.; Mochida, Y.; Takeda, K, Nakano, H, Rothe, M, Miyazono, K.; Ichijo, H. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol. Cell, 1998, 2, 389-395 (Pubitemid 128379279)
77. Perfeito, R.; Pereira, J.; Oliveira, C.R.; Bettencourt-Relvas, J.; Rego, A.C. Trolox protection of myelin membrane in hydrogen peroxide-treated mature oligodendrocytes. Free Radic. Res., 2007, 41(4), 444-451
78. Ye, P.; Kollias, G.; D'Ercole, A.J. Insulin-like growth factor-I ameliorates demyelination induced by tumor necrosis factor-alpha in transgenic mice. J. Neurosci. Res., 2007, 85(4), 712-722
79. Genovese, T.; Mazzon, E.; Crisafulli, C.; Di Paola, R.; Muià, C.; Bramanti, P.; Cuzzocrea, S. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J. Pharmacol. Exp. Ther., 2006, 316(3), 1006-1016 (Pubitemid 43345272)
80. Cheng, B; Christakos, S; Mattson, MP. Tumor necrosis factors protect neurons against metabolic excitotoxic insults and promote maintenance of calcium homeostasis. Neuron, 1994, 12(1), 139-153 (Pubitemid 24044394)
81. Mizuno, T; Sawada, M; Marunouchi, T; Suzumura, A. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun., 1994, 205(3), 1907-1915
82. Bethea, J.R.; Nagashima, H.; Acosta, M.C.; Briceno, C.; Gomez, F.; Marcillo, A.E.; Loor, K.; Green, J.; Dietrich, W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-α production and significantly improves functional recovery following spinal cord injury in rats. J. Neurotrauma, 1999, 16, 851-863
83. Genovese, T.; Esposito, E.; Mazzon, E.; Di Paola, R.; Caminiti, R.; Bramanti, P.; Cappelani, A.; Cuzzocrea, S. Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J. Neurochem., 2009, 108(6), 1360-1372
84. Rosenberg, L.J.; Teng, Y.D.; Wrathall, J.R. 2,3-Dihydroxy-6-nitro-7- sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion. J. Neurosci., 1999, 19, 464-475 (Pubitemid 29028985)
85. Rosin, C.; Colombo, S.; Calver, A.A.; Bates, T.E.; Skaper, S.D. Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation. Glia, 2005, 52(4), 336-343
86. Zhang, Y.; Bhavnani, B.R. Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci., 2006, 7, 49.
87. Ha, K.Y.; Kim, Y.H.; Rhyu, K.W.; Kwon, S.E. Pregabalin as a neuroprotector after spinal cord injury in rats. Eur. Spine J., 2008, 17(6), 864-872
88. Tian, D.S.; Liu, J.L.; Xie, M.J.; Zhan, Y.; Qu, W.S.; Yu, Z.Y.; Tang, Z.P. Pan, D.J.; Wang, W. Tamoxifen attenuates inflammatory-mediated damage and improves functional outcome after spinal cord injury in rats. J. Neurochem., 2009, 109(6), 1658-1667
89. Obata, T.; Kubota, S. Protective effect of tamoxifen on 1-methyl-4-phenylpyridine-induced hydroxyl radical generation in the rat stratium. Neurosci. Lett. 2001, 308(2), 87-90. (Pubitemid 32703674)
90. Feng, Y.; Fratkins, J.D.; LeBlanc, M.H. Treatment with tamoxifen reduces hypoxic-ischemic brain injury in neonatal rats. Eur. J. Pharmacol., 2004, 484(1), 65-74. (Pubitemid 38068535)
91. Osuka, K.; Feustel, P.J.; Mongin, A.A.; Tranmer, B.I.; KimelbergH, K. Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat. J. Neurochem., 2001, 76(6), 1842-1850.
92. Smilack, J.D. The tetracyclines. Mayo Clin. Proc., 1999, 74(7), 727-729
93. Klein, N.C.; Cunha, B.A. Tetracyclines. Med. Clin. North Am., 1995, 79(4), 789-801.
94. Stirling, D.P.; Khodarahmi, K.; Liu, J.; McPhail, L.T.; McBride, C.B.; Steeves, J.D.; Ramer, M.S.; Tetzlaff, W. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J. Neurosci., 2004, 24(9), 2182-2190 (Pubitemid 38314550)
95. Arnold, P.M.; ASystemic administration of minocycline improves functional recovery and morphometric analysis after spinal cord injury. 2001, Soc. Neurosci.
96. Lee, S.M.; Yune, T.Y.; Kim, S.J.; Park, D.W.; Lee, Y.K.; Kim, Y.C.; Oh, Y.J.; Markelonis, G.J.; Oh, T.H. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J. Neurotrauma, 2003, 20(10), 1017-1027
97. Horiuchi, H.; Ogata, T.; Morino, T.; Chuai, M.; Yamamoto, H. Continuous intrathecal infusion of SB203580, a selective inhibitor of p38 mitogen-activated protein kinase, reduces the damage of hind-limb function after thoracic spinal cord injury in rat. Neurosci. Res., 2003, 47(2), 209-217 (Pubitemid 37152457)
98. Lin, S.; Zhang, Y.; Dodel, R.; Farlow, M.R.; Paul, S.M.; Du, Y. Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons. Neurosci. Lett., 2001, 315(1-2), 61-64 (Pubitemid 33049999)
99. Yong, VW.; Wells, J.; Giuliani, F.; Casha, S.; Power, C.; Metz, L.M. The promise of minocycline in neurology. Lancet Neurol., 2004, 3(12), 744-751
100. Zurita, M.; Vaquero, J.; Oya, S.; Morales, C. Effects of dexamethasone on apoptosis-related cell death after spinal cord injury. J. Neurosurg. (Spine 1), 2002, 96, 83-89 (Pubitemid 34226544)
101. Xu, F.; Fan, G.; Chen, S.; Wu, Y.; Xu, X.M.; Hsu, C. Methylprednisolone inhibition of TNF-α expression and Nf-κB activation after spinal cord injury in rats. Mol. Brain Res., 1998, 59, 135-142 (Pubitemid 28434496)
102. Genovese, T.; Mazzon, E.; Crisafulli, C.; Esposito, E.; Di Paola, R.; Muià, C.; Di Bella, P.; Meli, R.; Bramanti, P.; Cuzzocrea, S. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma. Neuroscience, 2007, 150(1), 168-181 (Pubitemid 350214494)
103. Lee, J.M.; Yan, P.; Xiao, Q.; Chen, S.; Lee, K.Y.; Hsu, C.Y.; Xu, J. Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury. J. Neurosci., 2008, 28(12), 3141-3149 (Pubitemid 351442296)
104. Xu, J.; Chen, S.; Chen, H.; Xiao, Q.; Hsu, C.Y.; Michael, D.; Bao, J. STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes. J. Neurosci., 2009, 29(7), 2022-2026
105. Tegla, CA.; Cudrici, C.; Rus, V.; Ito, T.; Vlaicu, S.; Singh, A.; Rus, H. Neuroprotective effects of the complement terminal pathway during demyelination: implications for oligodendrocyte survival. J. Neuroimmunol., 2009, 213(1-2), 3-11.
106. Cudrici, C.; Niculescu, T.; Niculescu, F.; Shin, M.L.; Rus, H. Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement. J. Rehabil. Res. Dev., 2006, 43(1), 123-132 (Pubitemid 43938753)
107. Rus, H.; Cudrici, C.; Niculescu, F. C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection. Ann. Med., 2005, 37(2), 97-104 (Pubitemid 40593281)
108. Chang, A.; Tourtellotte, W.W.; Rudick, R.; Trapp, B.D. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med., 2002, 346, 165-173. (Pubitemid 34438882)
109. Goldman, J.E. What are the characteristics of cycling cells in the adult central nervous system? J. Cell Biochem., 2003, 88, 20-23. (Pubitemid 36015070)
110. Reynolds, R.; Cenci di Bello, I.; Dawson, M.; Levine, J. The response of adult oligodendrocyte progenitors to demyelination in EAE. Prog. Brain Res., 2001, 132, 165-174 (Pubitemid 33733872)
111. Watanabe, M.; Toyama, Y.; Nishiyama, A. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J. Neurosci. Res., 2002, 69, 826-836 (Pubitemid 34984700)
112. Frohman, E.M.; Racke, M.K.; Raine, C.S. Multiple sclerosis-the plaque and its pathogenesis. N. Engl. J. Med., 2006, 354(9), 942-955
113. Kuhlmann, T.; Miron, V.; Cuo, Q.; Wegner, C.; Antel, J.; Brück, W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain, 2008, 131(Pt 7), 1749-1758 (Pubitemid 351957453)
114. Arnett, H.A.; Mason, J.; Marino, M.; Suzuki, K.; Matsushima G.K.; Ting, J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci., 2001, 4(11), 1116-1122
115. van Oosten, B.W.; Barkhof, F.; Truyen, L.; Boringa, J.B.; Bertelsmann, F.W.; von Blomberg, B.M.; Woody, J.N.; Hartung, H.P.; Polman, C.H. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal antitumor necrosis factor antibody cA2. Neurology, 1996, 47(6), 1531-1534
116. Franklin, R.J.; Kotter, M.R.; The biology of CNS remyelination: the key totherapeutic advances. J. Neurol., 2008, 255 Suppl. 1, 19-25.
117. De Nicola, A.F.; Labombarda, F.; Deniselle, M.C.; Gonzalez, S.L.; Garay, L.; Meyer, M.; Gargiulo, G.; Guennoun, R.; Schumacher, M. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front. Neuroendocrinol., 2009, 30(2), 173-187
118. Ligon, K.L.; Fancy, S.P.; Franklin, R.J.; Rowitch, D.H. Olig gene function in CNS development and disease. Glia, 2006, 54(1), 1-10. (Pubitemid 43980029)
119. Guo, Q.; Sayeed, I.; Baronne, L.M.; Hoffman, S.W.; Guennoun, R.; Stein, D.G. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp. Neurol., 2006, 198(2), 469-478
120. Li, S.; Liu, B.P.; Budel, S.; Li, M.; Ji, B.; Walus, L.; Li, W.; Jirik, A.; Rabacchi, S.; Choi, E.; Worley, D.; Sah, D.W.; Pepinsky, B.; Lee, D.; Relton, J.; Strittmatter, S.M. Blockade of Nogo-66, myelin associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J. Neurosci., 2004, 24(46), 10511-10520.
121. Allsopp, T. E.; Kiselev, S.; Wyatt, S.; Davies, A. M. Role of Bcl-2 in the brain-derived neurotrophic factor survival response. Eur. J. Neurosci., 1995, 7, 1266-1272.
122. Riccio, A.; Ahn, S.; Davenport, C. M.; Blendy, J. A.; Ginty, D. D. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science, 1999, 286, 2358-2361.
123. Saini, H.S.; Gorse, K.M.; Boxer, L.M.; Sato-Bigbee, C. NT-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells. J. Neurochem., 2004, 89, 951-961.
124. Heinrich, M.; Gorath, M.; Richter-Landsberg, C. Neurotrophin-3 (NT-3) modulates early differentiation of oligodendrocytes in rat brain cortical cultures. Glia, 1999, 28(3), 244-255
125. McTigue, D.M.; Horner, P.J.; Stokes, B.T.; Gage, F.H. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci., 1998, 18, 5354-5365.
126. Rubio, N.; Rodriguez, R.; Arevalo, M.A. In vitro myelination by oligodendrocyte precursor cells transfected with the neurotrophin-3 gene. Glia, 2004, 47(1), 78-87. (Pubitemid 38879708)
127. Coelho, R.P.; Yuelling, L.M.; Fuss, B.; Sato-Bigbee, C. Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes. Glia, 2009, (epub ahead of print).
128. Uchida, K.; Baba, H.; Maezawa, Y.; Furukawa, S.; Omiya, M.; Kokubo, Y.; Kubota, C.; Nakajima, H. Increased expression of neurotrophins and their receptors in the mechanically compressed spinal cord of the spinal cord of the spinal hyperostotic mouse (twy/twy). Acta Neuropathol., 2003, 106, 29-36. (Pubitemid 36806164)
129. Nakajima, H.; Uchida, K.; Kobayashi, S.; Inukai, T.; Horiuchi, Y.; Yayama, T.; Sato, R.; Baba, H. Rescue of rat anterior horn neurons after spinal cord injury by retrograde transfection of adenovirus vector carrying brain-derived neurotrophic factor gene. J. Neurotrauma, 2007, 24(4), 703-712 (Pubitemid 46996029)
130. Uchida, K.; Nakajima, H.; Inukai, T.; Takamura, T.; Kobayashi, S.; Furukawa, S.; Baba, H. Adenovirus-mediated retrograde transfer of neurotrophin-3 gene enhances survival of anterior horn neurons of twy/twy mice with chronic mechanical compression of the spinal cord. J. Neurosci. Res., 2008, 86(8), 1789-1800 (Pubitemid 351859429)
131. Armstrong, R.C.; Le, T.Q.; Frost, E.E.; Borke, R.C.; Vana, A.C. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J. Neurosci., 2002, 22(19), 8574-8585
132. Calzà, L.; Fernández, M.; Giuliani, A.; Aloe, L.; Giardino, L. Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A., 2002, 99(5), 3258-3263 (Pubitemid 34240619)
133. Calzà, L.; Fernandez, M.; Giuliani, A.; D'Intino, G.; Pirondi, S.; Sivilia, S.; Paradisi, M.; Desordi, N.; Giardino, L. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease. Brain Res. Rev., 2005, 48(2), 339-346 (Pubitemid 40585764)
134. Fernandez, M.; Giuliani, A.; Pirondi, S.; D'Intino, G.; Giardino, L.; Aloe, L.; Levi-Montalcini, R.; Calzà, L. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc. Natl. Acad. Sci. U.S.A., 2004, 101(46), 16363-16368 (Pubitemid 39552850)
135. Fernandez, M.; Pirondi, S.; Manservigi, M.; Giardino, L.; Calzà, L. Thyroid hormone participates in the regulation of neural stem cells and oligodendrocyte precursor cells in the central nervous system of adult rat. Eur. J. Neurosci., 2004, 20(8), 2059-2070 (Pubitemid 39331126)
136. Giardino, L.; D'Intino, G.; Lorenzini, L.; Del vecchio, G.; Perretta, G.; Tagioni, A.; Villoslada, P.; Calzà, L. 2007 Thyroid hormone administration favours remyelination inexperimental allergic encephalomyelitis in the non human primate marmoset (Callithrix jacchus) 2007, 37th SfN 335.2.
137. Calza, L.; Fernandez, M.; Giardino, L. Cellular approaches to CNS remyelination stimulation: Thyroid hormone to promote myelin repair via endogenous stem and precursor cells. J. Mol. Endocrinol., 2009.
138. Vana, A.C.; Flint, N.C.; Harwood, N.E.; Le, T.Q.; Fruttiger, M.; Armstrong, R.C. Platelet-derived growth factor promotes repair of chronically demyelinated white matter. J. Neuropathol. Exp. Neurol., 2007, 66(11), 975-988
139. Finzsch, M.; Stolt, C.C.; Lommes, P.; Wegner, M. Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression. Development, 2008, 135(4), 637-646 (Pubitemid 351405017)
140. Pang, Y.; Zheng, B.; Fan, L.W.; Rhodes, P.G.; Cai, Z. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway. Glia, 2007, 55(11), 1099-1107 (Pubitemid 47204202)
141. + oligodendrocyte progenitors. Glia, 2004, 46(2), 183-194
142. Mozell, R.L.; McMorris, F.A. Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures. J. Neurosci. Res., 1991, 30(2), 382-390
143. D'Ercole, A.J.; Ye, P.; Calikoglu, A.S.; Gutierrez-Ospina, G. The role of the insulin-like growth factors in the central nervous system. Mol. Neurobiol., 1996, 13, 227-255. (Pubitemid 126715878)
144. Werther, G.A.; Russo, V.; Baker, N.; Butler, G. The role of the insulin-like growth factor system in the developing brain. Horm. Res., 1998, 49 Suppl 1, 37-40.
145. Kumar, S.; Biancotti, J.C.; Yamaguchi, M.; de Vellis, J. Combination of Growth Factors Enhances remyelination in a cuprizone-induced demyelination mouse model. Neurochem. Res., 2007, 32(4-5), 783-797